Blood filtering showdown: can lower volume save young livers?

NCT ID NCT06831643

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a standard volume of plasma exchange (blood filtering) works as well as a high volume in children aged 3 to 18 with acute liver failure. The goal is to see which approach helps more children survive without needing a liver transplant by day 21. Forty participants will be randomly assigned to one of the two treatments, and researchers will also monitor side effects and recovery of liver function.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
therapeutic plasma exchange (blood filtering)
What this could lead to
If successful, this could show that a lower volume of plasma exchange is just as effective as high volume, reducing risks and strain on blood bank resources for children with acute liver failure.
What could go wrong
This is a small pilot study with only 40 children, so results may not be definitive. Both procedures carry risks like transfusion reactions or infections, and the trial may not prove one method is clearly better.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE LIVER FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Institute of Liver & Biliary Sciences

    RECRUITING

    New Delhi, National Capital Territory of Delhi, 110070, India

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.